Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of a new selective ERAP1 inhibitor for Hedgehog-dependent cancer treatment.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods.

Food chemistry: X·2025
Same author

A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors.

Molecular diversity·2025
Same author

A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

Cancers·2024
Same author

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

International journal of molecular sciences·2023
Same author

Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective.

Journal of medicinal chemistry·2023
Same journal

A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cells.

Biochemical and biophysical research communications·2026
Same journal

NAT10-mediated RNA N4-acetylation promotes intestinal fibroblast senescence via DHRS2.

Biochemical and biophysical research communications·2026
Same journal

Deciphering potent MPL activation by the fucose-binding lectin thrombocorticin.

Biochemical and biophysical research communications·2026
Same journal

Mitochondrial genome alterations in cancer: From mutations and epigenetics to targeted therapiesack.

Biochemical and biophysical research communications·2026
Same journal

GPC3 chimeric antigen receptor (CAR)-NK cells combined with Enoblituzumab enhance the anti-tumor efficacy against hepatocellular carcinoma.

Biochemical and biophysical research communications·2026
Same journal

A miR-382-5p-PORCN axis modulates endogenous Wnt signaling during palatal development.

Biochemical and biophysical research communications·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
06:19

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

Published on: March 10, 2023

4.8K

Exploiting ALDH1A2 and ALDH1A3 isoform variability for crystallisation screening.

Sonia Siragusa1, Silvia Garavaglia1, Marco Mazzorana2

  • 1Department of Scienze del Farmaco, University of Piemonte Orientale, Via Bovio, 6, Novara, 28100, Italy.

Biochemical and Biophysical Research Communications
|August 19, 2025
PubMed
Summary
This summary is machine-generated.

Researchers report the first apo-ALDH1A2 structure using nanoliter crystallisation, advancing drug discovery for aldehyde dehydrogenase 1A2 (ALDH1A2). This method also streamlines structural studies for ALDH1A3, aiding in exploring ligand libraries.

Keywords:
ALDH1A2ALDH1A3AldehydesCancer stem cellsStructure-based drug discovery

More Related Videos

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
09:59

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity

Published on: March 31, 2023

1.1K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.8K

Related Experiment Videos

Last Updated: Sep 10, 2025

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
06:19

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

Published on: March 10, 2023

4.8K
Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
09:59

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity

Published on: March 31, 2023

1.1K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.8K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Enzymology

Background:

  • Aldehyde dehydrogenase 1A proteins (ALDH1As) are vital for converting retinal to retinoic acid.
  • ALDH1As are recognized as cancer stem cell markers linked to tumor aggressiveness.
  • Existing structural data for ALDH1A2 primarily comes from ligand-bound forms via vapor diffusion.

Purpose of the Study:

  • To present the first apo-ALDH1A2 structure obtained through nanoliter sitting-drop crystallization.
  • To investigate the crystallizability of NAD+-ALDH1A3 using microliter drops.
  • To propose robotic-compatible strategies for streamlining structural studies of ALDH1A3.

Main Methods:

  • Nanoliter sitting-drop crystallization for apo-ALDH1A2.
  • Microliter drop crystallization for NAD+-ALDH1A3.
  • Comparison of apo-ALDH1A2 and NAD+-ALDH1A3 structures.

Main Results:

  • The first apo-ALDH1A2 structure was successfully obtained using nanoliter crystallization.
  • The study explored crystallization conditions for NAD+-ALDH1A3.
  • Comparative structural analysis between apo-ALDH1A2 and NAD+-ALDH1A3 was performed.

Conclusions:

  • Nanoliter crystallization offers a new avenue for obtaining apo-ALDH1A2 structures, enhancing drug discovery potential.
  • The findings facilitate structural studies on ALDH1A3, supporting extensive ligand library exploration.
  • Optimized crystallization strategies are proposed for robotic applications in ALDH1A3 structural research.